CCM
RVMD icon

Coldstream Capital Management’s Revolution Medicines RVMD Stock Holding History

Coldstream Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$433K Buy
+2,314
New +$338K 0.01% 804
2025
Q2 		– Sell
-1,238
Closed -$43.8K – 2893
2025
Q1 		$43.8K Buy
+1,238
New +$50.3K ﹤0.01% 1769

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Coldstream Capital Management's RVMD Position: Q2 2026 in Review

Coldstream Capital Management opened a new position in Revolution Medicines (RVMD) in Q2 2026: 2,314 shares worth $433K. The stake represents 0.01% of the portfolio and ranks #804 among its holdings. This is a return to the name: Coldstream Capital Management previously reported a position in RVMD as recently as Q1 2025.

Coldstream Capital Management first reported a position in RVMD in Q1 2025 and has held it in 2 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Coldstream Capital Management held 2,314 shares of Revolution Medicines worth $433K as of Q2 2026.
  • Revolution Medicines was a new Coldstream Capital Management position in Q2 2026.
  • Revolution Medicines made up 0.01% of Coldstream Capital Management's portfolio in Q2 2026, its #804 holding.
  • Coldstream Capital Management first reported a position in Revolution Medicines in Q1 2025 and has held it in 2 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.